Stay updated on Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page.

Latest updates to the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page footer revision indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a documentation/build version change rather than an adjustment to the study details.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a minor update to the page without altering core content.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedWebsite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; there are no visible changes to the study details, eligibility criteria, or outcomes on the page.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded gastric cancer as a condition and introduced the Genetic and Rare Diseases Information Center as a resources link; updated the page revision to v3.4.2 and removed the government funding status notice.SummaryDifference0.6%

- Check90 days agoChange DetectedA site-wide notice about a lapse in government funding was added, directing users to cc.nih.gov and opm.gov for status updates. The page revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page.